This
program presents an analysis of AECB,
as well as teach and discuss the complications and problems associated
with these conditions. Participants receive an up-to-date review
of national treatment guideline recommendations, as well as patient
treatment strategies for the uncomplicated patient, the complicated
patient, and the patient at risk for infection with P.aeruginosa.
Specially
selected case studies highlight major categories within AECB.
Through the use of hi-tech diagnostic video clips,
participants are presented with actual patient interviews and
examinations. Chest radiographs, audio/video lung clips, and
select laboratory
data is shown and discussed. Course content is based on the principles
of evidence-based medicine.
Educational
Objectives:
- Define the role of infection in exacerbations of COPD
- Identify
the etiology of AECB
- Explore the role of appropriate
diagnostic tests
- Define
algorithms for therapy that focus on the infectious and
non-infectious components of illness
for AECB
- Identify the issues involved in "antimicrobial
resistance"
- Describe
therapy guidelines and therapeutic approaches toAECB
back
to top
|
Lionel Mandell, MD
Professor of Medicine and Chief of the Division of Infectious Diseases
McMaster University
Hamilton, Ontario, Canada
Michael Niederman, MD
Chairman, Department of Medicine
Winthrop University Hospital
Mineola, New York
Michael E. Pichichero, MD
Professor
of Pediatrics, Medicine and Microbiology/Immunology
University of Rochester Medical Center
Department of Microbiology/Immunology
Rochester, New York
| Faculty |
| Antonio
Anzueto, MD |
Joseph
P. Lynch, MD |
| Robert
Baughman, MD |
Fernando
J. Martinez, MD |
| Richard
Brown, MD |
Steve
Nelson, MD |
| Stanley
Fiel, MD |
Lance
Peterson, MD |
| Tom
File, MD |
George
A. Sarosi, MD |
| Paul
Iannini, MD |
Steve
Zinner, MD |
|
